Differential Ly6C Expression after Renal Ischemia-Reperfusion Identifies Unique Macrophage Populations

Journal of the American Society of Nephrology

Volumn 27, Issue 1, 2016, Pages 159-170

  Clements, Meghan ^a   Gershenovich, Michael ^a   Chaber, Christopher ^a   Campos Rivera, Juanita ^a   Du, Pan ^a   Zhang, Mindy ^a   Ledbetter, Steve ^a   Zuk, Anna ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; COLONY STIMULATING FACTOR 1; PROTEIN; PROTEIN LY6C; UNCLASSIFIED DRUG; VIMENTIN; LY ANTIGEN; LY-6C ANTIGEN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE IDENTIFICATION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY ISCHEMIA; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WOUND HEALING; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CLASSIFICATION; KIDNEY; METABOLISM;

ANIMALS; ANTIGENS, LY; KIDNEY; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; PHENOTYPE; REPERFUSION INJURY;

EID: 84954421002     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014111138     Document Type: Article

References (61)

1. Bonventre JV, Yang L: Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 121: 4210-4221, 2011
2. Sharfuddin AA,Molitoris BA: Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol 7: 189-200, 2011
3. Cerdá J, Lameire N, Eggers P, Pannu N, Uchino S, Wang H, Bagga A, Levin A: Epidemiology of acute kidney injury. Clin J Am Soc Nephrol 3: 881-886, 2008
4. Humphreys BD, Valerius MT, Kobayashi A, Mugford JW, Soeung S, Duffield JS, McMahon AP, Bonventre JV: Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2: 284-291, 2008
5. Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR: Long-term risk of mortality and other adverse outcomes after acute kidney injury: A systematic review and meta-analysis. AmJ Kidney Dis 53: 961-973, 2009
6. Hsu CY, Ordoñez JD, Chertow GM, Fan D, McCulloch CE, Go AS: The risk of acute renal failure in patients with chronic kidney disease. Kidney Int 74: 101-107, 2008
7. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, Collins AJ: Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 20: 223-228, 2009
8. Lo LJ,Go AS, ChertowGM,McCulloch CE, Fan D,Ordoñez JD,Hsu CY: Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 76: 893-899, 2009
9. Venkatachalam MA, Griffin KA, Lan R, Geng H, Saikumar P, Bidani AK: Acute kidney injury: A springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 298: F1078-F1094, 2010
10. Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV: Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 16: 535-543, 1p, 143, 2010
11. Clements ME, Chaber CJ, Ledbetter SR, Zuk A: Increased cellular senescence and vascular rarefaction exacerbate the progression of kidney fibrosis in aged mice following transient ischemic injury. PLoS ONE 8: E70464, 2013
12. Duffield JS: Macrophages and immunologic inflammation of the kidney. Semin Nephrol 30: 234-254, 2010
13. Wang Y, Harris DC: Macrophages in renal disease. J Am Soc Nephrol 22: 21-27, 2011
14. Eardley KS, Zehnder D, Quinkler M, Lepenies J, Bates RL, Savage CO, Howie AJ, Adu D, Cockwell P: The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. Kidney Int 69: 1189-1197, 2006
15. Sica A, Mantovani A: Macrophage plasticity and polarization: In vivo veritas. J Clin Invest 122: 787-795, 2012
16. Murray PJ, Wynn TA: Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11: 723-737, 2011
17. Anders HJ, Ryu M: Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int 80: 915-925, 2011
18. Ramachandran P, Pellicoro A, Vernon MA, Boulter L, Aucott RL, Ali A, Hartland SN, Snowdon VK, Cappon A,Gordon-Walker TT,Williams MJ, Dunbar DR, Manning JR, van Rooijen N, Fallowfield JA, Forbes SJ, Iredale JP: Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci U S A 109: E3186-E3195, 2012
19. Lin SL, Castaño AP, Nowlin BT, Lupher ML Jr, Duffield JS: Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J Immunol 183: 6733-6743, 2009
20. Gordon S, Taylor PR: Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964, 2005
21. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, Chazaud B: Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J ExpMed 204: 1057-1069, 2007
22. Ingersoll MA, Spanbroek R, Lottaz C, Gautier EL, Frankenberger M, Hoffmann R, Lang R, Haniffa M, Collin M, Tacke F, Habenicht AJ, Ziegler-Heitbrock L, Randolph GJ: Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 115: E10-e19, 2010
23. Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, Merad M, Luedde T, Trautwein C, Tacke F: Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50: 261-274, 2009
24. Movahedi K, Laoui D, Gysemans C, Baeten M, Stangé G, Van den Bossche J, Mack M, Pipeleers D, In't Veld P, De Baetselier P, Van Ginderachter JA: Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res 70: 5728-5739, 2010
25. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, Pittet MJ: The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J ExpMed 204: 3037-3047, 2007
26. Lee S,Huen S, NishioH, Nishio S, LeeHK, Choi BS, RuhrbergC, Cantley LG: Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 22: 317-326, 2011
27. Hirsch S, Austyn JM, Gordon S: Expression of the macrophage-specific antigen F4/80 during differentiation of mouse bone marrow cells in culture. J ExpMed 154: 713-725, 1981
28. Pixley FJ, Stanley ER: CSF-1 regulation of the wandering macrophage: Complexity in action. Trends Cell Biol 14: 628-638, 2004
29. Ko GJ, Boo CS, Jo SK, Cho WY, Kim HK: Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusioninduced acute kidney injury. Nephrol Dial Transplant 23: 842-852, 2008
30. Ma FY, Liu J, Kitching AR, Manthey CL, Nikolic-Paterson DJ: Targeting renal macrophage accumulation via c-fms kinase reduces tubular apoptosis but fails to modify progressive fibrosis in the obstructed rat kidney. Am J Physiol Renal Physiol 296: F177-F185, 2009
31. Murray PJ, Allen JE, Biswas SK, Fisher EA,GilroyDW,Goerdt S,Gordon S, Hamilton JA, Ivashkiv LB, Lawrence T, Locati M, Mantovani A, Martinez FO, Mege JL, Mosser DM, Natoli G, Saeij JP, Schultze JL, Shirey KA, Sica A, Suttles J, Udalova I, van Ginderachter JA, Vogel SN, Wynn TA: Macrophage activation and polarization: Nomenclature and experimental guidelines. Immunity 41: 14-20, 2014
32. Zhang MZ, Yao B, Yang S, Jiang L, Wang S, Fan X, Yin H, Wong K, Miyazawa T, Chen J, Chang I, Singh A, Harris RC: CSF-1 signaling mediates recovery fromacute kidney injury.JClinInvest 122: 4519-4532, 2012
33. Lehtonen A, Ahlfors H, Veckman V,MiettinenM, Lahesmaa R, Julkunen I:Gene expression profiling during differentiation of human monocytes to macrophages or dendritic cells. J Leukoc Biol 82: 710-720, 2007
34. Ji JD, Park-Min KH, Ivashkiv LB: Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages. Hum Immunol 70: 211-217, 2009
35. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686, 2004
36. Manthey CL, Johnson DL, Illig CR, Tuman RW, Zhou Z, Baker JF, Chaikin MA, Donatelli RR, Franks CF, Zeng L, Crysler C, Chen Y, Yurkow EJ, Boczon L, Meegalla SK, Wilson KJ, Wall MJ, Chen J, Ballentine SK, Ott H, Baumann C, Lawrence D, Tomczuk BE, Molloy CJ: JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia. Mol Cancer Ther 8: 3151-3161, 2009
37. Li L, Huang L, Sung SS, Vergis AL, Rosin DL, Rose CE Jr, Lobo PI,Okusa MD: The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int 74: 1526-1537, 2008
38. Day YJ, Huang L, Ye H, Linden J, Okusa MD: Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: Role of macrophages. Am J Physiol Renal Physiol 288: F722-F731, 2005
39. Van Rooijen N, Sanders A: Liposome mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications. J Immunol Methods 174: 83-93, 1994
40. Menke J, Iwata Y, Rabacal WA, Basu R, Yeung YG, Humphreys BD, Wada T, Schwarting A, Stanley ER, Kelley VR: CSF-1 signals directly to renal tubular epithelial cells to mediate repair inmice.JClin Invest 119: 2330-2342, 2009
41. Chen Q, DeFrances MC, Zarnegar R: Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during humanmonocytemacrophage differentiation. Cell Growth Differ 7: 821-832, 1996
42. Liu H, Shi B, Huang C-C, Eksarko P, Pope RM: Transcriptional diversity during monocyte to macrophage differentiation. Immunol Lett 117: 70-80, 2008
43. LambDJ,Modjtahedi H, Plant NJ, FernsGAA: EGFmediatesmonocyte chemotaxis and macrophage proliferation and EGF receptor is expressed in atherosclerotic plaques. Atherosclerosis 176: 21-26, 2004
44. Gutiérrez-Fernández A, InadaM, BalbínM, Fueyo A, Pitiot AS, Astudillo A, Hirose K, Hirata M, Shapiro SD, Noël A, Werb Z, Krane SM, López-Otín C, Puente XS: Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J 21: 2580-2591, 2007
45. Kyriakides TR, Wulsin D, Skokos EA, Fleckman P, Pirrone A, Shipley JM, Senior RM, Bornstein P: Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis. Matrix Biol 28: 65-73, 2009
46. Schmidt IM, Hall IE, Kale S, Lee S, He CH, Lee Y, Chupp GL, Moeckel GW, Lee CG, Elias JA, Parikh CR, Cantley LG: Chitinase-like protein Brp-39/YKL-40 modulates the renal response to ischemic injury and predicts delayed allograft function. J Am Soc Nephrol 24: 309-319, 2013
47. Park WD, Griffin MD, Cornell LD, Cosio FG, Stegall MD: Fibrosis with inflammation at one year predicts transplant functional decline. J Am Soc Nephrol 21: 1987-1997, 2010
48. Park WD, Stegall MD: A meta-analysis of kidney microarray datasets: Investigation of cytokine gene detection and correlation with rt-PCR and detection thresholds. BMC Genomics 8: 88, 2007
49. SochaMJ,Manhiani M, Said N, Imig JD,Motamed K: Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension. Am J Pathol 171: 1104-1112, 2007
50. Wang JC, Lai S, Guo X, Zhang X, de Crombrugghe B, Sonnylal S, Arnett FC, Zhou X: Attenuation of fibrosis in vitro and in vivo with SPARC siRNA. Arthritis Res Ther 12: R60, 2010
51. Fan D, Takawale A, Basu R, Patel V, Lee J, Kandalam V, Wang X, Oudit GY, Kassiri Z: Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction. Cardiovasc Res 103: 268-280, 2014
52. WynesMW, Frankel SK, RichesDW: IL-4-inducedmacrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal. J Leukoc Biol 76: 1019-1027, 2004
53. Butt RP, Laurent GJ, Bishop JE: Mechanical load and polypeptide growth factors stimulate cardiac fibroblast activity. Ann N Y Acad Sci 752: 387-393, 1995
54. Brown KM, Sacks SH, Sheerin NS: Mechanisms of disease: The complement system in renal injury-new ways of looking at an old foe. Nat Clin Pract Nephrol 3: 277-286, 2007
55. Chawla LS, Eggers PW, Star RA, Kimmel PL: Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371: 58-66, 2014
56. Gupta J,MitraN, Kanetsky PA,Devaney J,WingMR, ReillyM, Shah VO, Balakrishnan VS, Guzman NJ, GirndtM, Periera BG, Feldman HI, Kusek JW, Joffe MM, Raj DS; CRIC Study Investigators: Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol 7: 1938-1946, 2012
57. Illig CR, Chen J, Wall MJ, Wilson KJ, Ballentine SK, Rudolph MJ, DesJarlais RL, Chen Y, Schubert C, Petrounia I, Crysler CS, Molloy CJ, Chaikin MA, Manthey CL, Player MR, Tomczuk BE, Meegalla SK: Discovery of novel FMS kinase inhibitors as anti-inflammatory agents. Bioorg Med Chem Lett 18: 1642-1648, 2008
58. Zuk A, Gershenovich M, Ivanova Y, MacFarland RT, Fricker SP, Ledbetter S: CXCR4 antagonism as a therapeutic approach to prevent acute kidney injury. Am J Physiol Renal Physiol 307: F783-F797, 2014
59. Zuk A, Bonventre JV, Brown D, Matlin KS: Polarity, integrin, and extracellularmatrix dynamics in the postischemic rat kidney. Am J Physiol 275: C711-C731, 1998
60. Oga T, Matsuoka T, Yao C, Nonomura K, Kitaoka S, Sakata D, Kita Y, Tanizawa K, Taguchi Y, Chin K, Mishima M, Shimizu T, Narumiya S: Prostaglandin F(2alpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta.Nat Med 15: 1426-1430, 2009
61. Liu T, Baek HA, Yu H, Lee HJ, Park BH, Ullenbruch M, Liu J, Nakashima T, Choi YY, Wu GD, Chung MJ, Phan SH: FIZZ2/RELM-b induction and role in pulmonary fibrosis. J Immunol 187: 450-461, 2011